Australia TGA ARTG record

Angiography contrast medium injection system, line-powered, mobile

Australia TGA ARTG Registered Device · Intervene Medical Pty Ltd · Angiodroid SpA · Class IIb · Started November 02, 2021

Good Name: Intervene Medical Pty Ltd - Angiography contrast medium injection system, line-powered, mobile

Device classification

Risk Class: Class IIb
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: November 02, 2021
Effective Date: November 02, 2021

Sponsor

Name: Intervene Medical Pty Ltd

Manufacturer

Name: Angiodroid SpA
Country: Italy
Address: Via Speranza 35, San Lazzaro di Savana, BO, 40068

Intended purpose

The device allows the intravascular injection of CO2, with precise volume dose and injection pressure, to perform Automated Carbon Dioxide Angiography (ACDA). CO2 acts as a contrast agent in an angiographic examination.

About this record

Access comprehensive regulatory information for Angiography contrast medium injection system, line-powered, mobile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Intervene Medical Pty Ltd, manufactured by Angiodroid SpA in Italy. The device registration started on November 02, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.